Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active Surveillance for Oesophageal Cancer (SANO-trial): a Phase-III Stepped-wedge Cluster Randomised Trial

NCT05953181 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT05953181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05953181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active Surveillance for Oesophageal Cancer (SANO-trial): a Phase-III Stepped-wedge Cluster Randomised Trial
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 1, 2017
Completion date
June 1, 2026
Enrollment
776 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

active surveillance, esophageal cancer, neoadjuvant chemoradiotherapy, surgical oncology